Medy Tsalic

602 total citations
12 papers, 338 citations indexed

About

Medy Tsalic is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Medy Tsalic has authored 12 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Medy Tsalic's work include Neutropenia and Cancer Infections (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Colorectal and Anal Carcinomas (2 papers). Medy Tsalic is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Colorectal and Anal Carcinomas (2 papers). Medy Tsalic collaborates with scholars based in Israel, United Kingdom and Egypt. Medy Tsalic's co-authors include Gil Bar‐Sela, Nissim Haim, Hadassah Goldberg, Boris Futerman, Shai Linn, Dan Hershko, Ofer Ben‐Izhak, Maanit Shapira, Diana Gaitini and Alex Beny and has published in prestigious journals such as SHILAP Revista de lepidopterología, Breast Cancer Research and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Medy Tsalic

12 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Medy Tsalic Israel 7 142 102 99 78 61 12 338
Robin Gurganus United States 9 61 0.4× 314 3.1× 74 0.7× 73 0.9× 41 0.7× 15 459
K Nishiyama Japan 9 91 0.6× 126 1.2× 38 0.4× 155 2.0× 25 0.4× 40 405
Jarosław Szefel Poland 12 133 0.9× 83 0.8× 123 1.2× 37 0.5× 29 0.5× 25 374
Jingjing Shao China 11 111 0.8× 73 0.7× 155 1.6× 48 0.6× 23 0.4× 36 366
Wenxuan Yu China 11 69 0.5× 46 0.5× 109 1.1× 29 0.4× 44 0.7× 24 304
Sara Bahadoram Iran 6 41 0.3× 120 1.2× 141 1.4× 35 0.4× 22 0.4× 15 309
Lydia Posch Austria 9 72 0.5× 111 1.1× 120 1.2× 52 0.7× 12 0.2× 13 317
Xiao Zheng China 7 115 0.8× 88 0.9× 82 0.8× 79 1.0× 10 0.2× 19 314
Keiichiro Genka Japan 12 183 1.3× 121 1.2× 164 1.7× 85 1.1× 8 0.1× 24 529

Countries citing papers authored by Medy Tsalic

Since Specialization
Citations

This map shows the geographic impact of Medy Tsalic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Medy Tsalic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medy Tsalic more than expected).

Fields of papers citing papers by Medy Tsalic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Medy Tsalic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Medy Tsalic. The network helps show where Medy Tsalic may publish in the future.

Co-authorship network of co-authors of Medy Tsalic

This figure shows the co-authorship network connecting the top 25 collaborators of Medy Tsalic. A scholar is included among the top collaborators of Medy Tsalic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Medy Tsalic. Medy Tsalic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Bar‐Sela, Gil, Medy Tsalic, Mariana Steiner, Mirjana Wollner, & Nissim Haim. (2009). Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma.. PubMed. 29(5). 1853–6. 2 indexed citations
3.
Bar‐Sela, Gil, et al.. (2007). Wheat Grass Juice May Improve Hematological Toxicity Related to Chemotherapy in Breast Cancer Patients: A Pilot Study. Nutrition and Cancer. 58(1). 43–48. 65 indexed citations
4.
Tsalic, Medy, et al.. (2006). Epiphora (Excessive Tearing) and Other Ocular Manifestations Related to Weekly Docetaxel: Underestimated Dose-Limiting Toxicity. Medical Oncology. 23(1). 57–62. 13 indexed citations
5.
Bar‐Shalom, Rachel, Ludmila Guralnik, Medy Tsalic, et al.. (2005). The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. European Journal of Nuclear Medicine and Molecular Imaging. 32(8). 918–924. 87 indexed citations
6.
Haim, Nissim, Katerina Shulman, Hadassah Goldberg, & Medy Tsalic. (2005). The Safety of Full-Dose Chemotherapy with Secondary Prophylactic Granulocyte Colony Stimulating Factor (G-CSF) Following a Prior Cycle with Febrile Neutropenia. Medical Oncology. 22(3). 229–232. 11 indexed citations
7.
Shapira, Maanit, Ofer Ben‐Izhak, Shai Linn, et al.. (2005). The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Research. 7(5). R737–44. 81 indexed citations
8.
Tsalic, Medy, et al.. (2003). Severe Toxicity Related to the 5-Fluorouracil/Leucovorin Combination (The Mayo Clinic Regimen). American Journal of Clinical Oncology. 26(1). 103–106. 53 indexed citations
9.
Tsalic, Medy, et al.. (2003). Actual Body Weight for Determining Doses of Chemotherapy in Obese Cancer Patients: Evaluation of Treatment Tolerability. Medical Oncology. 20(4). 363–368. 15 indexed citations
10.
Bar‐Sela, Gil, et al.. (2003). Paclitaxel, Carboplatin, and Oral Etoposide in Advanced Gastric Adenocarcinoma: Association with Severe Myelotoxicity. Medical Oncology. 20(3). 291–294. 4 indexed citations
11.
Tsalic, Medy, et al.. (2003). . American Journal of Clinical Oncology. 26(1). 103–106. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026